Workflow
Normal Course Issuer Bid
icon
Search documents
D-BOX Technologies Announces Normal Course Issuer Bid
Globenewswire· 2026-03-23 21:01
MONTREAL, March 23, 2026 (GLOBE NEWSWIRE) -- D-BOX Technologies Inc. (“D-BOX” or the “Corporation”) (TSX:DBO) today announced that the Toronto Stock Exchange (the “TSX”) has accepted the Corporation's Notice of Intention to make a normal course issuer bid (the “NCIB”). The NCIB will commence on March 27, 2026 and will terminate on March 26, 2027, or such earlier date as the Corporation may complete its purchases pursuant to the Notice of Intention filed with the TSX. Under the NCIB, the Corporation is autho ...
Knight Amends Normal Course Issuer Bid
Globenewswire· 2026-03-23 12:36
Core Viewpoint - Knight Therapeutics Inc. has announced an amendment to its Normal Course Issuer Bid (NCIB), increasing the maximum number of common shares to be repurchased from 3,000,000 to 6,190,493, which represents approximately 10% of the public float as of August 8, 2025 [1]. Group 1: Share Repurchase Details - The company intends to repurchase common shares for cancellation through the Toronto Stock Exchange (TSX) or alternative Canadian trading systems, with the number and timing to be determined by the company [2]. - From August 22, 2025, to March 19, 2026, the company has already purchased 1,767,300 common shares at a weighted average price of $6.08 per share [2]. Group 2: Automatic Share Purchase Plan - Knight has amended its Automatic Share Purchase Plan (ASPP) with its broker to align with the increased number of common shares authorized for repurchase under the amended NCIB, allowing the broker to repurchase shares even during regulatory restrictions or blackout periods [3]. Group 3: Company Overview - Knight Therapeutics Inc. is a specialty pharmaceutical company based in Montreal, Canada, focused on acquiring, in-licensing, and commercializing pharmaceutical products for Canada and Latin America, with subsidiaries operating under United Medical, Biotoscana Farma, and Laboratorio LKM [4].
DPM Metals Announces Renewal of Normal Course Issuer Bid
Globenewswire· 2026-03-16 11:45
Core Viewpoint - DPM Metals Inc. has announced the renewal of its normal course issuer bid to repurchase shares, indicating a strategic move to enhance shareholder value through share buybacks [1][2]. Group 1: Previous and New Bid Details - The previous bid, initiated on March 18, 2025, allowed the repurchase of up to 15 million shares, approximately 9.8% of the public float as of March 4, 2025, with 3,508,460 shares repurchased at a weighted average price of US$16.06 (Cdn $22.39) per share as of March 11, 2026 [1][2]. - The new bid will commence on March 18, 2026, and will allow the purchase of up to 11 million shares, representing about 4.96% of the issued and outstanding common shares as of March 11, 2026, totaling 221,763,788 shares [2]. Group 2: Purchase Mechanism and Regulations - All purchases under the new bid will be conducted through the TSX or alternative trading systems, with shares purchased being cancelled [2]. - The company will not acquire more than 286,745 shares on any given trading day, which is 25% of the average daily trading volume of 1,146,983 shares over the last six months, except for block purchase exceptions [2]. Group 3: Automatic Share Purchase Plan (ASPP) - An automatic share purchase plan has been established to facilitate share purchases during regulatory restrictions or self-imposed black-out periods, effective March 18, 2026 [3]. Group 4: Financial Management and Strategy - RBC Capital Markets has been re-appointed to execute purchases under the new bid, with the timing and number of shares purchased being influenced by the company's share price, financial position, and capital allocation strategy [4]. - DPM Metals Inc. aims to become a mid-tier precious metals company through sustainable and efficient gold production, focusing on quality asset development and maintaining a strong financial position for growth [5].
Xtra-Gold Announces 2026 Normal Course Issuer Bid and Results of 2025 Bid
TMX Newsfile· 2026-03-13 12:00
Core Viewpoint - Xtra-Gold Resources Corp. has announced its intention to renew its normal course issuer bid to purchase up to 4,000,000 common shares, reflecting the belief that the current market price does not fully represent the company's underlying value and future prospects [1][2]. Group 1: Issuer Bid Details - The 2026 Bid will commence on March 18, 2026, and terminate on March 17, 2027, or earlier if the targeted shares from the 2025 Bid are repurchased [3]. - The 4,000,000 common shares represent approximately 10% of the public float of 41,514,562 shares as of March 4, 2026 [3]. - All shares will be purchased on the open market through TSX facilities, with payment made according to TSX policies [4]. Group 2: Purchase Mechanics - The maximum number of common shares that may be purchased daily is 4,465, which is 25% of the average daily trading volume of 17,863 over the last six months [5]. - The company has engaged Haywood Securities Inc. to act as the broker for the 2026 Bid [5]. Group 3: Previous Bid Results - Under the previous normal course issuer bid (2025 Bid), the company purchased 365,600 common shares at an average price of $3.06 per share from March 18, 2025, to March 4, 2026 [7].
Strathcona Resources Ltd. Receives TSX Approval for Normal Course Issuer Bid
Prnewswire· 2026-03-12 21:00
Core Viewpoint - Strathcona Resources Ltd. has received approval from the Toronto Stock Exchange to initiate a normal course issuer bid (NCIB) to repurchase up to 5% of its outstanding common shares, aiming to enhance long-term shareholder returns as the market price does not reflect the underlying value of the business [1]. Group 1: NCIB Details - The NCIB allows Strathcona to purchase up to 10,711,780 common shares, based on 214,235,608 shares outstanding as of March 5, 2026 [1]. - Purchases will be made through the TSX and other designated exchanges, with a limit of 25% of the average daily trading volume, which is 162,460 shares for the six-month period from September 1, 2025, to February 28, 2026 [1]. - The NCIB will commence on March 17, 2026, and will expire on March 16, 2027, or when the maximum number of shares is acquired [1]. Group 2: Company Overview - Strathcona is recognized as one of North America's fastest-growing pure play heavy oil producers, focusing on thermal oil and enhanced oil recovery [1]. - The company employs an innovative growth strategy through the consolidation and development of long-life assets [1].
MAPLE LEAF FOODS RECEIVES TSX APPROVAL TO PROCEED WITH NORMAL COURSE ISSUER BID
Prnewswire· 2026-03-11 11:00
Core Viewpoint - Maple Leaf Foods Inc. has received approval from the Toronto Stock Exchange (TSX) to initiate a normal course issuer bid (NCIB) program, allowing the company to repurchase up to 7,300,000 common shares over the next year, which represents 9.73% of the public float [1][1][1] Summary by Relevant Sections NCIB Program Details - The NCIB program will commence on March 13, 2026, and will end on March 12, 2027, unless completed earlier [1] - The company is authorized to purchase up to 7,300,000 common shares, which is 9.73% of the public float of 74,997,436 common shares as of March 2, 2026 [1] - Daily purchases on the TSX are limited to a maximum of 76,396 common shares, which is 25% of the average daily trading volume for the six months ended February 28, 2026 [1] Previous NCIB Performance - Under the previous NCIB approved on March 11, 2025, the company repurchased 658,800 common shares at a weighted average price of $28.74 per share [1] - The prior NCIB for the purchase of up to 7,400,000 common shares will expire on March 12, 2026 [1] Rationale for NCIB - The company believes that the market price of its common shares may not fully reflect their value, making the repurchase an attractive use of available funds [1] - All shares repurchased under the NCIB will be cancelled [1] Purchase Mechanism - Purchases will be made at the market price at the time of acquisition, and the company has established an automatic share purchase plan with its designated broker for certain pre-determined blackout periods [1] - Outside of these blackout periods, purchases will be made at management's discretion, subject to applicable law [1] Company Overview - Maple Leaf Foods is a leading protein-focused consumer packaged goods company based in Mississauga, Ontario, producing food under various brands [1] - The company is committed to safety, sustainability, and innovation, aiming to deliver shared value for all stakeholders [1]
Hydreight Announces Normal Course Issuer Bid
Prnewswire· 2026-03-09 12:00
Core Viewpoint - Hydreight Technologies Inc. announces a normal course issuer bid to purchase up to 4,951,189 common shares, representing approximately 9.27% of the outstanding shares, to enhance shareholder value and stabilize market pricing [1] Company Overview - Hydreight Technologies Inc. is a provider of digital health infrastructure and on-demand healthcare services across the United States, aiming to build one of the largest mobile clinic networks [1] - The company has developed a proprietary platform that connects over 3,000 nurses and 300 doctors, facilitating healthcare services directly to patients in various settings [1] - Hydreight's platform includes integrated tools for managing patient data, accounting, and sales, empowering healthcare professionals to operate independently [1] Normal Course Issuer Bid Details - The issuer bid will commence on March 12, 2026, and terminate on March 11, 2027, or earlier if completed [1] - The bid will be conducted in accordance with applicable securities laws and will be funded from existing working capital [1] - The company believes that the current market price does not reflect its business strength and growth potential, justifying the share buyback [1] VSDHOne Platform - Hydreight launched the VSDHOne platform in partnership with Victory Square Technologies, aimed at simplifying entry for businesses into the online healthcare space [1] - The platform offers compliant healthcare services, including GLP-1s, peptides, and personalized treatments, allowing businesses to launch direct-to-consumer healthcare brands quickly [1] - VSDHOne provides a comprehensive solution, reducing the time and costs associated with entering the online healthcare market [1]
Pan American Silver Announces Renewal of Normal Course Issuer Bid
Businesswire· 2026-03-04 11:00
Core Viewpoint - Pan American Silver Corp. has announced the renewal of its normal course issuer bid to purchase up to 21,090,323 common shares, representing 5% of its issued shares as of February 28, 2026, with the bid period running from March 6, 2026, to March 5, 2027 [1] Group 1: Bid Details - The Toronto Stock Exchange has accepted the company's notice for the renewal of the normal course issuer bid [1] - The company intends to purchase shares on the open market through TSX, NYSE, and alternative trading systems [1] - The maximum daily purchases on TSX will be 304,358 shares, which is 25% of the average daily trading volume for the six months ended February 28, 2026 [1] Group 2: Financial Context - Under the current issuer bid, which started on March 6, 2025, the company has purchased 819,558 shares at an average price of approximately C$52.43 per share [1] - As of February 28, 2026, the total number of issued and outstanding common shares is 421,806,464 [1] - The company believes that the market price of its shares may not fully reflect the underlying value of its mining operations and future growth prospects [1] Group 3: Strategic Rationale - The board of directors views the outstanding common shares as an accretive investment, allowing the company to utilize excess cash for attractive risk-adjusted returns [1] - An automatic securities purchase plan has been established to facilitate share repurchases even during internal trading blackout periods [1]
Allied Announces Renewal Of Normal Course Issuer Bid
Globenewswire· 2026-02-24 12:25
Core Viewpoint - Allied Properties Real Estate Investment Trust has received approval for a normal course issuer bid to repurchase up to 18,215,302 units, representing approximately 10% of its public float, primarily to fulfill employee commitments and potentially for cancellation [1][2]. Group 1: Normal Course Issuer Bid (NCIB) Details - The NCIB will commence on February 26, 2026, and will expire on February 25, 2027, or earlier if purchases are completed [2]. - Purchases will be made on the open market at prevailing market prices, with a daily limit of 213,464 units, which is 25% of the average daily trading volume over the past six months [2]. - The previous NCIB, which started on February 26, 2025, allowed for the purchase of up to 12,615,599 units, with 1,062 units repurchased at a weighted average price of $16.86 [3]. Group 2: Employee Programs and Repurchase Plans - The primary purpose of the NCIB is to fulfill commitments under Allied's restricted unit plan and other employee programs [1]. - Allied may enter into pre-defined plans with its broker to repurchase units during internal trading blackout periods, adhering to Canadian securities laws [4]. Group 3: Company Overview - Allied is a leading owner-operator of distinctive urban workspace in major Canadian cities, focusing on sustainable and wellness-oriented environments for knowledge-based organizations [6].
Pender Growth Fund Provides Notice of its Intention to Undertake Normal Course Issuer Bid
Globenewswire· 2026-02-17 18:25
Core Viewpoint - The Company intends to initiate a Normal Course Issuer Bid (NCIB) to enhance shareholder value and invest its cash balance effectively, as the market price of its Class C common shares may not reflect its underlying value and growth prospects [2]. Group 1: NCIB Details - The Company plans to implement a new NCIB upon the expiration of the previous one launched in February 2025 [2]. - The NCIB is subject to acceptance by the TSX Venture Exchange (TSXV) and is set to commence on February 20, 2026, and end on February 19, 2027, unless terminated earlier [6]. - The Company is entitled to purchase up to 585,681 Shares, which is 10% of its public float of 5,856,814 Shares [3]. Group 2: Share Purchase Mechanism - Shares acquired under the NCIB will be purchased at market price and executed by Ventum Financial Corp., the Company's broker [4]. - An automatic share purchase plan has been established with Ventum to facilitate repurchases during regulatory restrictions or blackout periods [5]. Group 3: Company Overview - Pender Growth Fund aims for long-term capital appreciation, focusing on small-cap, special situations, and illiquid public and private companies [7]. - The Company trades on the TSX Venture Exchange under the symbol "PTF" and posts its Reporting NAV on its website within five business days of each month end [7].